医药与保健
醫藥與保健
의약여보건
Medicine and Health Care
2015年
8期
93-94
,共2页
许俊盛%方悦丽%黄丽珊%蔡美妆%杜俊涛
許俊盛%方悅麗%黃麗珊%蔡美妝%杜俊濤
허준성%방열려%황려산%채미장%두준도
维D钙%葡萄糖酸钙%妊娠期缺钙
維D鈣%葡萄糖痠鈣%妊娠期缺鈣
유D개%포도당산개%임신기결개
Victoria D Calcium%calcium gluconate%calcium deficiency during pregnancy
目的：观察妊娠期补充维D钙咀嚼片或葡萄糖酸钙口服液的临床效果。方法将160例妊娠20周妇女随机分成两组，观察组80例，口服维D钙咀嚼片，对照组80例，口服葡萄糖酸钙口服液，两组孕妇补钙前查血钙，补钙后分别于孕28、36周复查血钙，并定期产前检查。结果观察组孕28周、孕36周血钙分别为2.45±0.11、2.33±0.17（mmol/L），对照组孕28周、孕36周血钙分别为2.13±0.12、2.08±0.12（mmol/L），观察组血钙较对照组明显升高，两组比较差异有统计学意义（X2分别为4.479、3.151，均P<0.05），观察组的临床缺钙症状明显低于对照组，且妊娠期高血压疾病、胎儿生长受限、产后出血、副反应发生率均明显低于对照组，两组比较差异有统计学意义（X2分别为138.53、134.79、452.82、137.19、208.47，均P<0.05）。结论孕期补充维D钙咀嚼片可明显改善缺钙症状、降低妊娠期高血压疾病、胎儿生长受限及产后出血发生率。
目的：觀察妊娠期補充維D鈣咀嚼片或葡萄糖痠鈣口服液的臨床效果。方法將160例妊娠20週婦女隨機分成兩組，觀察組80例，口服維D鈣咀嚼片，對照組80例，口服葡萄糖痠鈣口服液，兩組孕婦補鈣前查血鈣，補鈣後分彆于孕28、36週複查血鈣，併定期產前檢查。結果觀察組孕28週、孕36週血鈣分彆為2.45±0.11、2.33±0.17（mmol/L），對照組孕28週、孕36週血鈣分彆為2.13±0.12、2.08±0.12（mmol/L），觀察組血鈣較對照組明顯升高，兩組比較差異有統計學意義（X2分彆為4.479、3.151，均P<0.05），觀察組的臨床缺鈣癥狀明顯低于對照組，且妊娠期高血壓疾病、胎兒生長受限、產後齣血、副反應髮生率均明顯低于對照組，兩組比較差異有統計學意義（X2分彆為138.53、134.79、452.82、137.19、208.47，均P<0.05）。結論孕期補充維D鈣咀嚼片可明顯改善缺鈣癥狀、降低妊娠期高血壓疾病、胎兒生長受限及產後齣血髮生率。
목적：관찰임신기보충유D개저작편혹포도당산개구복액적림상효과。방법장160례임신20주부녀수궤분성량조，관찰조80례，구복유D개저작편，대조조80례，구복포도당산개구복액，량조잉부보개전사혈개，보개후분별우잉28、36주복사혈개，병정기산전검사。결과관찰조잉28주、잉36주혈개분별위2.45±0.11、2.33±0.17（mmol/L），대조조잉28주、잉36주혈개분별위2.13±0.12、2.08±0.12（mmol/L），관찰조혈개교대조조명현승고，량조비교차이유통계학의의（X2분별위4.479、3.151，균P<0.05），관찰조적림상결개증상명현저우대조조，차임신기고혈압질병、태인생장수한、산후출혈、부반응발생솔균명현저우대조조，량조비교차이유통계학의의（X2분별위138.53、134.79、452.82、137.19、208.47，균P<0.05）。결론잉기보충유D개저작편가명현개선결개증상、강저임신기고혈압질병、태인생장수한급산후출혈발생솔。
Objective To 0bserve the clinical efficacy of supplementation Victoria D Calcium Chewable Tablets or calcium gluconate oral solution during pregnancy. Methods 160 cases of women 20 weeks of pregnancy were randomly divided into two groups, 80 cases in the observation group, oral Victoria D Calcium Chewable Tablets, 80 cases in the control group, oral calcium gluconate oral solution, check calcium of the two groups of pregnant women before the investigation, review calciumat 28, 36 weeks after pregnancy calcium and regular prenatal care. Result Observer Group 28 weeks pregnant, 36 weeks pregnant calcium were 2.45± 0.11,2.33± 0.17 (mmol/L), the control group 28 weeks pregnant, 36 weeks pregnant calcium were 2.13 ± 0.12, 2.08 ± 0.12 (mmol/L). The observation group calcium was significantly higher than in the control group, the difference was statistically significant (x2 respectively 4.479、3.151, all P <0.05), the clinical symptoms of calcium deficiency in the observation group was significantly lower than the control group, and hypertensive disorders in pregnancy, fetal growth restriction, The incidence of postpartum hemorrhage was significantly lower than the control group, the difference was statistically significant (x2respectively138.53、134.79、452.82、137.19、208.47, all P<0.05).Conclusion Victoria D Calcium Chewable Tablets supplementation during pregnancy may reduce the incidence of calcium deficiency symptoms and reduce hypertensive disorders in pregnancy, fetal growth restriction and incidence of postpartum hemorrhage, very beneficial for the mother and child .
